MedTrace Logo

Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects

NCT00122044 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2014-05-23

No results posted yet for this study

Summary

This study is an open-label trial of trihexyphenidyl in children with upper extremity dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to 0.75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of upper extremity function.

Conditions

  • Dystonia

Interventions

DRUG

trihexyphenidyl

Sponsors & Collaborators

  • United Cerebral Palsy Foundation

    collaborator OTHER

  • Don and Linda Carter Foundation

    collaborator OTHER

  • Crowley Carter Foundation

    collaborator OTHER

  • University of Southern California

    lead OTHER

Principal Investigators

  • Terence D Sanger, MD, PhD · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2004-12-31
Completion
2004-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00122044 on ClinicalTrials.gov